POLYETHYLENE GLYCOL-3350 AND ELECTROLYTES

CHEBI:CHEBI_748344

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

active_ingredient_name
SODIUM SULFATE ANHYDROUS
rxcui
967012
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20241231
route
ORAL
marketing_category
ANDA
pharm_class
Potassium Salt [EPC]
pharm_class_moa
Osmotic Activity [MoA]
pharm_class_epc
Osmotic Laxative [EPC]
pharm_class_pe
Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
unii
36KCS0R750
nui
N0000009871
dosage_form
POWDER, FOR SOLUTION
labeler_name
Lupin Pharmaceuticals,Inc.
manufacturer_name
Lupin Pharmaceuticals,Inc.
generic_name
polyethylene glycol-3350 and Electrolytes
brand_name
GAVILYTE G TM
brand_name_base
GAVILYTE G
product_ndc
43386-090
application_number
ANDA090231
marketing_start_date
20090601
package_marketing_start_date
20090601
spl_id
cccea25c-6192-418e-a9ee-d97be10e7c69
active_ingredient_strength
22.74 g/274.31g
package_ndc
43386-090-19
package_description
274.31 g in 1 BOTTLE (43386-090-19)
spl_set_id
3978822b-6473-4072-9f80-20ceb9bea355
brand_name_suffix
TM
upc
0343386200023
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class